United States · Series E startup
Funding summaryUpdated 26 Oct 2026
$104Mraised across 4 rounds since 2006, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
OrbiMed
Highland Capital Partners
OVP Venture Partners
Enterprise Partners Venture Capital
Essex Woodlands Healthcare Partners
Prospect Venture PartnersReported by fiercebiotech.comSEC filing: $14M sold, first sale Feb 2009
No investor was named in the report.
From a historical funding recordSEC filing: $14M sold, first sale Feb 2009
From a historical funding record
From the SEC filings it signed: 2 on the team.
On the board, as filediAlexander E. BarkasAndrew SenyeiCharles P. Waite
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
OVP Venture PartnersEnterprise Partners Venture CapitalOrbiMedHighland Capital PartnersEssex Woodlands Healthcare PartnersProspect Venture Partners
Sands Capital VenturesMissing a round, or an investor who was in one? Tell us.
Complete Genomics's investors include OVP Venture Partners, Enterprise Partners Venture Capital, OrbiMed, Highland Capital Partners and Essex Woodlands Healthcare Partners, and 2 more on record.
Complete Genomics has raised $104M across 4 rounds since 2006.
Complete Genomics's most recent round was a Series E of $39M in Aug 2010.
Complete Genomics's largest round on record is $45M (Series D), in Aug 2009.
Complete Genomics's first round on record, in Mar 2006, was backed by OVP Venture Partners and Enterprise Partners Venture Capital.
Complete Genomics's latest named round is a Series E, in Aug 2010.
Complete Genomics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
